Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
GL Pharm Tech Corp banner
G

GL Pharm Tech Corp
KOSDAQ:204840

Watchlist Manager
GL Pharm Tech Corp
KOSDAQ:204840
Watchlist
Price: 1 096 KRW 0.37% Market Closed
Market Cap: ₩85B
Write Note Create Alert Ask AI

Gross Margin

43.6%
Current
Improving
by 6.3%
vs 3-y average of 37.4%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
43.6%
=
Gross Profit
₩15B
/
Revenue
₩34.3B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
43.6%
=
Gross Profit
₩15B
/
Revenue
₩34.3B

Peer Comparison

Country Company Market Cap Gross
Margin
KR
GL Pharm Tech Corp
KOSDAQ:204840
84.6B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
960.1B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
579.4B USD
Loading...
CH
Roche Holding AG
SIX:ROG
284.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.1B GBP
Loading...
CH
Novartis AG
SIX:NOVN
235.3B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
295.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
158B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.2B USD
Loading...

Market Distribution

Higher than 81% of companies in Korea
Percentile
81th
Based on 2 511 companies
81th percentile
43.6%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

Other Profitability Ratios

GL Pharm Tech Corp
Glance View

Market Cap
85B KRW
Industry
Pharmaceuticals

GL Pharm Tech Corp. engages in the provision of pharmaceutical research and development services and in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-11-20.

Intrinsic Value
1 026.85 KRW
Overvaluation 6%
Intrinsic Value
Price
G
What is Intrinsic Value?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
43.6%
=
Gross Profit
₩15B
/
Revenue
₩34.3B
What is GL Pharm Tech Corp's current Gross Margin?

The current Gross Margin for GL Pharm Tech Corp is 43.6%, which is above its 3-year median of 37.4%.

How has Gross Margin changed over time?

Over the last 3 years, GL Pharm Tech Corp’s Gross Margin has increased from 31.8% to 43.6%. During this period, it reached a low of 29.2% on Dec 31, 2022 and a high of 44.9% on Jun 30, 2025.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.